Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma 19Lymphoma, Large B-Cell, Diffuse 16Leukemia 11Lymphoma, Non-Hodgkin 10Burkitt Lymphoma 10Recurrence 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 6Neoplasms 5Lymphoma, B-Cell 5Leukemia, Myeloid, Acute 4Multiple Myeloma 3Medulloblastoma 3Lymphoma, T-Cell, Peripheral 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Sezary Syndrome 2Sarcoma, Ewing 2Neuroblastoma 2Neoplasms by Histologic Type 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphatic Diseases 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia, Biphenotypic, Acute 2

Interventions

Vincristine 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Tufted angioma × Vincristine × Clear all
NCT02110069 2023-09-21

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

Boston Children's Hospital

Phase 2 Terminated
4 enrolled 8 charts

Tufted angioma, Kaposiform Hemangioendothelioma, Hemangioendothelioma, Vascular Malformations, Kasabach-Merritt Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡